1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon‐a2a/ribavirin in combination with a direct‐acting anti‐viral – authors' reply. Issue 5 (13th August 2013) Authors: Ferenci, P.; Rutter, K. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 5(2013) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Polymorphisms of interferon‐λ4 and IL28B – effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Issue 1 (10th November 2013) Authors: Stättermayer, A. F.; Strassl, R.; Maieron, A.; Rutter, K.; Stauber, R.; Strasser, M.; Beinhardt, S.; Datz, C.; Scherzer, T.‐M.; Steindl‐Munda, P.; Gschwantler, M.; Trauner, M.; Hofer, H.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 1(2014) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durability of SVR in chronic hepatitis C patients treated with peginterferon‐α2a/ribavirin in combination with a direct‐acting anti‐viral. Issue 2 (26th May 2013) Authors: Rutter, K.; Hofer, H.; Beinhardt, S.; Dulic, M.; Gschwantler, M.; Maieron, A.; Laferl, H.; Stättermayer, A. F.; Scherzer, T.‐M.; Strassl, R.; Holzmann, H.; Steindl‐Munda, P.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 2(2013) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Successful anti‐viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C. Issue 6 (23rd January 2015) Authors: Rutter, K.; Stättermayer, A. F.; Beinhardt, S.; Scherzer, T.‐M.; Steindl‐Munda, P.; Trauner, M.; Ferenci, P.; Hofer, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 6(2015) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Review article: genetic factors that modify the outcome of viral hepatitis. Issue 10 (24th March 2014) Authors: Stättermayer, A. F.; Scherzer, T.; Beinhardt, S.; Rutter, K.; Hofer, H.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 10(2014) Page Start: 1059 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗